Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest
Jan Bělohlávek(Brigham and Women's Hospital), Hana Skalická(University of Iowa), Lucie Kompelentova, Petra Havránková(Charles University), Michael Aschermann, Aleš Král(Charles University), Jan Rulíšek(Charles University), Štěpán Havránek(Charles University), Milana Pokorná, Dan Romportl, Michal Pořízka, Petra Kaválková(Charles University), Tomáš Kovárník(Charles University), Michal Otáhal(Charles University), Arnošt Komárek(Charles University), Michal Huptych(Czech Technical University in Prague), Alan Mejstrik, Daniel Rob(Charles University), Michal Paďour, Martin Balík(Charles University), Markéta Hubatová, Jiří Jarkovský(Masaryk University), Jaroslav Pekara, Jana Šmalcová(Charles University), Jaroslav Valasek, Petr Kolouch, Ondřej Šmíd(General University Hospital in Prague), Anna Valeriánová(Charles University), David Peřan, Aleš Linhart(Charles University), Marek Flaksa, Helena Tomková, Ondřej Franěk, Ilona Lálová, František Mlejnský(Charles University), Jan Malík(Charles University), J Horák(Charles University), Jan Šimek, Vratislav Mrázek(Charles University), Petr Jeřábek, David Zemánek
Cited by 674
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k